STOCK TITAN

West Declares Quarterly Dividend

The dividend marks West's thirty-fourth consecutive annual increase.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
dividends

West Pharmaceutical Services (NYSE: WST) declared a fourth-quarter common-stock dividend of $0.26 per share, payable on November 18, 2026.

The dividend is an 18% increase over the prior quarter's $0.22 per share and marks the company's thirty-fourth consecutive annual dividend increase. Shareholders of record on November 11, 2026, will receive the payment.

Loading...
Loading translation...

Positive

  • Minor point. Forward-looking: it has not happened yet and may not happen.Fourth-quarter dividend of $0.26 per share increases 18% from the prior quarter's $0.22.
  • Minor pointThirty-fourth consecutive annual dividend increase extends the company's record of higher payouts.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

EXTON, Pa., Oct. 19, 2026 /PRNewswire/ -- On October 19, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared a fourth-quarter dividend of $0.26 per share on the Company's common stock, an 18% increase over the $0.22 per share paid in the prior quarter. This is the thirty-fourth consecutive annual increase in the Company's dividend. The dividend is payable on November 18, 2026, to shareholders of record on November 11, 2026.

About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life saving and life enhancing medicines for patients. With over 10,000 team members across 50 sites including 26 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.

Headquartered in Exton, Pennsylvania, West in its fiscal year 2025 generated $3.07 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com. 

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted. 

Media Contact:
Michele Polinsky
Vice President, Global Communications
+1-610-594-3054
Michele.Polinsky@westpharma.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/west-declares-quarterly-dividend-302913197.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much is West Pharmaceutical Services' fourth-quarter 2026 dividend?

The dividend is $0.26 per common share, an 18% increase over the $0.22 per share paid in the prior quarter.

When will West Pharmaceutical Services pay its fourth-quarter 2026 dividend?

West will pay the dividend on November 18, 2026, to shareholders of record on November 11, 2026.

Keep reading